Abstract

The present study demonstrated that in hypertensive, diabetic subjects, a rosiglitazone-based treatment strategy results in favourable changes in inflammatory biomarkers compared with metformin/glyburide.

Keywords

MedicineRosiglitazoneAdipokineDiabetes mellitusInternal medicineBioinformaticsEndocrinologyInsulin resistance

Affiliated Institutions

Related Publications

Publication Info

Year
2012
Type
article
Volume
17
Issue
4
Pages
191-6
Citations
2
Access
Closed

External Links

Citation Metrics

2
OpenAlex

Cite This

Milan Gupta, Hwee Teoh, Mahesh Kajil et al. (2012). The effects of rosiglitazone on inflammatory biomarkers and adipokines in diabetic, hypertensive patients.. PubMed , 17 (4) , 191-6.